Author: Jacqueline Deen, Principal House Officer, Dermatology, Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia. DermNet New Zealand Editor in Chief: Hon A/Prof Amanda Oakley, Dermatologist, Hamilton, New Zealand. Copy edited by Gus Mitchell. September 2019.
Trichothiodystrophy is a rare, multisystem, autosomal recessive disorder characterised by sulphur-deficient, short, brittle hair. Other clinical features may include photosensitivity, ichthyosis, intellectual impairment, haematological abnormalities, decreased fertility, and short stature .
The name trichothiodystrophy was coined by Price et al in 1979, and is derived from Greek: tricho (hair), thio (sulphur), dys (faulty), trophy (nourishment).
Trichothiodystrophy is classified into photosensitive and non-photosensitive sub-types .
The estimated incidence of trichothiodystrophy is one per million live births. Males and females are affected equally. Trichothiodystrophy has been described in various ethnic groups worldwide, although it occurs more commonly amongst populations where consanguinity is frequent [1,3].
Trichothiodystrophy is caused by defective DNA repair and transcription and is inherited in an autosomal recessive pattern, meaning both parents must have the mutated gene that causes trichothiodystrophy for the child to inherit it.
Trichothiodystrophy is characterised by sulphur-deficient, short, brittle hair, which is sparse and easily broken. Other clinical features are highly variable in expression. Approximately 50% of patients have associated photosensitivity, although this does not confer an increased risk of future skin cancer (unlike patients with xeroderma pigmentosa).
Other non-dermatological-associated abnormalities may include:
The clinical phenotype of trichothiodystrophy varies from mild disease with hair abnormalities to severe disease with recurrent infections and severe developmental defects. A number of acronyms have been created to describe the different clinical phenotypes seen.
Complications of trichothiodystrophy are mostly related to the high risk of acquiring severe and potentially life-threatening infections .
Trichothiodystrophy may be diagnosed by demonstrating low sulphur content on biochemical analysis of hair shafts, in addition to one of the following findings:
Differential diagnoses of trichothiodystrophy can include:
Cockayne syndrome is a rare autosomal recessive disorder of DNA repair, characterised by photosensitivity, a distinctive facial appearance, short stature, ocular abnormalities, premature ageing, and neurological dysfunction.
Xeroderma pigmentosum is a rare autosomal recessive condition of DNA repair, typified by the early development of pigmentary changes, an increased risk of ultraviolet radiation-induced skin and mucous membrane cancer, severe photosensitivity (50%), and in some individuals, progressive neurodegeneration (30%).
Menkes disease (also known as Menkes kinky hair syndrome) is a congenital X-linked genetic disorder where copper deficiency causes peculiar ‘kinked' (sharply bent) hair, neurodegeneration and connective tissue abnormalities.
Netherton syndrome is a rare autosomal recessive condition of cornification characterised by a triad of inflammatory and scaly skin lesions, a characteristic hair-shaft abnormality labelled trichorrhexis invaginata (‘bamboo hair’) and an increased incidence of allergic diseases such as food allergy, urticaria, and atopic dermatitis [2,3].
Patients with trichothiodystrophy typically have complex health care needs and benefit from a multidisciplinary approach, with input from paediatrics, genetics, ophthalmology, neurology, obstetrics, orthopaedics, infectious diseases, dermatology, and radiology. Appropriate genetic counselling should be offered to affected patients and their families.
Given there is no cure for trichothiodystrophy, treatment is largely based on managing clinical manifestations, symptoms, and complications. Patients who are photosensitive should be provided with sun protection advice. Infections should be treated early and aggressively .
Given there is no cure for trichothiodystrophy, the prognosis is typically poor for children with severe disease and the median age of death is reported as 3 years. During the neonatal and childhood period, there is substantial morbidity and mortality, with pneumonia and other infections (particularly sepsis) being the leading causes of death .
© 2019 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.